Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06189781 · ClinicalTrials.gov registry record · Phase 4

Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

A Phase 4 study of Pain, Postoperative and Cerebral Palsy, sponsored by University of California, Los Angeles.

Recruiting
Registry status
Phase 4
Development phase
90
Enrollment target
4
Study locations

NCT06189781 is a Phase 4 study of Pain, Postoperative and Cerebral Palsy that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 90 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (67% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06189781, a Phase 4 study of Pain, Postoperative and Cerebral Palsy, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
Phase 4
Development phase
90 participants
Enrollment target
4
Study locations

Study Summary

Pain management in pediatric patients presents a difficult challenge. Unlike adults, pediatric patients often cannot communicate their pain management needs clearly. This is especially true in patients with cerebral palsy (CP), who often have concomitant developmental delay, intellectual disability and verbal limitations. Current literature indicates pain as a common experience for children with CP but has been understudied in this population. Moreover, inadequate post-operative pain control can result in negative physiologic and psychological complications and lead to poor surgical outcomes. Currently, perioperative pain management following orthopaedic procedures in pediatric patients follows traditional protocols that rely on the administration of opioid medications despite their known adverse side effects including nausea, vomiting, itching, constipation, urinary retention, confusion, and respiratory depression. Epidural anesthesia is a key modality in traditional pain management for pediatric patients with CP given its proven efficacy in decreasing pain and managing spasticity. Yet, administering epidural anesthesia in this patient population poses several risks including damage to preexisting intrathecal baclofen pumps, iatrogenic infection, and technically demanding insertion given high rates of concomitant neuromuscular scoliosis. Alternatively, multimodal analgesic injections theoretically offer an efficacious adjunct to traditional pain management protocols with a lower risk profile. Preliminary data from our study group's pilot randomized control trial comparing the safety and efficacy of a multimodal surgical site injection to placebo showed decreased pain scores and narcotic consumption postoperatively in this patient population. Based on these promising results, the objective of this randomized control trial is to evaluate the efficacy of a multimodal surgical site injection compared to epidural anesthesia for postoperative pain control following oper

Interventions

  • DRUG Ropivacaine injection
  • DRUG Bupivacaine, lidocaine, ropivacaine

Study Locations (4)

California

  • Orthopaedic Institute for Children - Los Angeles
  • Ronald Reagan UCLA Medical Center - Los Angeles
  • UCLA Medical Center, Santa Monica - Santa Monica

Illinois

  • Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-12-01
Est. Completion 2027-06-30
Phase Phase 4

What the Registry Record Tells You About NCT06189781

The ClinicalTrials.gov registry entry for NCT06189781 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (67% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Ropivacaine injection is the first listed.

NCT06189781 reports 4 study locations spanning 2 distinct geographic areas - top geographies include California, Illinois.

Frequently Asked Questions

What is clinical trial NCT06189781 about?

NCT06189781 is a clinical study titled "Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy". Pain management in pediatric patients presents a difficult challenge. Unlike adults, pediatric patients often cannot communicate their pain management needs clearly. This is especially true in patients with cerebral palsy (CP), who often have concomitant developmental delay, intellectual disability ...

What is the current status of trial NCT06189781?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2023-12-01. Estimated completion is 2027-06-30.

What conditions does trial NCT06189781 study?

This clinical trial studies the following conditions: Pain, Postoperative, Cerebral Palsy, Hip Dysplasia.

What interventions are being tested in trial NCT06189781?

The interventions under investigation include: Ropivacaine injection (DRUG), Bupivacaine, lidocaine, ropivacaine (DRUG).

Who is sponsoring clinical trial NCT06189781?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06189781 being conducted?

This trial has 4 study locations across California, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.